Aristopin (Atropine 0.01%) is an anticholinergic drug. Aristopin is indicated to control myopia progression in pediatric patients (4-14 years).

Description

Aristopin (Atropine 0.01) is an anticholinergic drug. Aristopin O/Sol effectively slows the progression of childhood myopia, as evidenced by clinical studies and endorsements from leading ophthalmology organizations. With its low-dose 0.01% Atropine formulation, Aristopin minimizes common side effects, making it suitable for long-term use in children. The duration of treatment with Aristopin (Atropine 0.01%) O/Sol, can vary depending on the individual child's response and the progression of their myopia. Generally, the treatment is recommended for a minimum of two years. However, it can be continued up to the age of 12 or until the child's eye growth stabilizes.

Presentation

    Aristopin Ophthalmic Solution: Each ml contains Atropine Sulfate USP 0.1 mg.

Indications

    Aristopin is indicated to control the progression of myopia in paediatric patients (4-14 years).

Dosage & Administration

    One drop topically in eye(s) once at night.

Contrainidications

    Persons with glaucoma or a tendency toward glaucoma, and with hypersensitivity to belladonna alkaloids.

Warning & Precautions

    • For ophthalmic use only.
    • Excessive use may produce symptoms of systemic atropine poisoning.
    • Only paediatric use.

Side effects

    • May be associated with a stinging sensation on instillation.
    • May cause allergy (itch, irritation, and redness), blurring of near vision, and glare in some children.

Drug interaction

    Atropine Ophthalmic Solution may interact with monoamine oxidase inhibitors (MAOIs).

Use in special groups

Packing

    Aristopin Ophthalmic Solution: Each LDPE dropper bottle contains 5 ml Sterile Eye Drops.